Nanosphere

About

Nanosphere develops a molecular diagnostics platform for genomic and protein testing and analysis.

Northbrook,Illinois,United States
51 - 100

Highlights

Details

Last Funding Type: Series D
Last Funding Money Raised: $57M
Industries: Biotechnology,Genetics,Health Care,Medical
Founded date: Jan 1, 1999
Number Of Employee: 51 - 100
Operating Status: Active
Stock Symbol: nasdaq:NSPH
Legal Name: Nanosphere, Inc.

Nanosphere, Inc. is a nanotechnology-based healthcare company, making clinical diagnostic tests that are two to three times as sensitive as those commonly used in hospital labs today and much simpler, taking just hours rather than days or weeks to complete. The company's instruments, which use microfluidics to pull DNA and proteins from a sample, detect genetic variations in blood that make some drugs more effective in some patients than others. The key is an array of gold nanoparticles studded with chemicals that capture characteristic proteins and nucleic acids from clinical samples such as blood.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$223.07M

Nanosphere has raised a total of $223.07M in funding over 2 rounds. Their latest funding was raised on May 29, 2015 from a Post-IPO Debt round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
May 29, 2015	Post-IPO Debt	$4.07M	—	—	—	Detail
Sep 19, 2013	Post-IPO Equity	$30.20M	—	—	—	Detail
Nov 9, 2007	IPO	$98M	—	—	—	Detail
May 16, 2006	Series D	$57M	3	Bain Capital	—	Detail
Jan 6, 2003	Series C	$5M	3	Lurie Investment Fund	—	Detail